
Biogenesis helps individuals improve health outcomes by combining personal device data, genomic insights, and medical records into actionable guidance. It uses AI and data integration to aggregate wearables, genomic profiles, and EMR data, apply analytics and risk models, and deliver personalized recommendations and tracking. The product is a consumer-facing digital health platform (B2C) with integrations to wearables and electronic medical record systems and support for genomic data ingestion. Core technologies include machine learning, secure health data interoperability (EMR/HIPAA-aware integrations), and consumer mobile/web interfaces. The platform targets the personal health market by enabling continuous monitoring and data-driven care decisions.

Biogenesis helps individuals improve health outcomes by combining personal device data, genomic insights, and medical records into actionable guidance. It uses AI and data integration to aggregate wearables, genomic profiles, and EMR data, apply analytics and risk models, and deliver personalized recommendations and tracking. The product is a consumer-facing digital health platform (B2C) with integrations to wearables and electronic medical record systems and support for genomic data ingestion. Core technologies include machine learning, secure health data interoperability (EMR/HIPAA-aware integrations), and consumer mobile/web interfaces. The platform targets the personal health market by enabling continuous monitoring and data-driven care decisions.
Product: Consumer-facing digital health platform that aggregates wearables, genomic data, and EMRs to deliver personalized recommendations
Tech: Machine learning, secure health data interoperability, mobile/web consumer interfaces
Founding year: 2024
Location (reported): Palo Alto, California
Reported funding: Seed-stage funding with named investors including Alt Capital and Greylock
Personalized consumer health and continuous monitoring
2024
Biotechnology
2750000
Seed round; investors named across reports include Alt Capital, Greylock, Formic Ventures, Kleiner Perkins, Cory Levy, Kian Sadeghi, Pareto Holdings
“Investors named include Alt Capital, Greylock, Formic Ventures, Kleiner Perkins, Cory Levy, Kian Sadeghi, Pareto Holdings”